Annual CAPEX:
$11.07M-$11.22M(-50.34%)Summary
- As of today, IOVA annual capital expenditures is $11.07 million, with the most recent change of -$11.22 million (-50.34%) on December 31, 2024.
- During the last 3 years, IOVA annual CAPEX has fallen by -$26.50 million (-70.54%).
- IOVA annual CAPEX is now -76.34% below its all-time high of $46.79 million, reached on December 31, 2020.
Performance
IOVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$7.46M+$1.25M(+20.13%)Summary
- As of today, IOVA quarterly capital expenditures is $7.46 million, with the most recent change of +$1.25 million (+20.13%) on June 30, 2025.
- Over the past year, IOVA quarterly CAPEX has increased by +$7.02 million (+1588.01%).
- IOVA quarterly CAPEX is now -68.03% below its all-time high of $23.34 million, reached on December 31, 2020.
Performance
IOVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$20.13M+$7.02M(+53.54%)Summary
- As of today, IOVA TTM capital expenditures is $20.13 million, with the most recent change of +$7.02 million (+53.54%) on June 30, 2025.
- Over the past year, IOVA TTM CAPEX has increased by +$8.41 million (+71.76%).
- IOVA TTM CAPEX is now -67.27% below its all-time high of $61.50 million, reached on June 30, 2021.
Performance
IOVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
IOVA CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -50.3% | +1588.0% | +71.8% |
3Y3 Years | -70.5% | +63.0% | -39.5% |
5Y5 Years | +60.0% | +50.0% | -25.1% |
IOVA CAPEX Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -70.5% | at low | -21.6% | +1588.0% | -19.4% | +93.0% |
5Y | 5-Year | -76.3% | +60.0% | -68.0% | +1588.0% | -67.3% | +93.0% |
All-Time | All-Time | -76.3% | >+9999.0% | -68.0% | >+9999.0% | -67.3% | >+9999.0% |
IOVA CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $7.46M(+20.1%) | $20.13M(+53.5%) |
Mar 2025 | - | $6.21M(+49.0%) | $13.11M(+18.4%) |
Dec 2024 | $11.07M(-50.3%) | $4.17M(+82.2%) | $11.07M(+6.1%) |
Sep 2024 | - | $2.29M(+417.6%) | $10.43M(-11.0%) |
Jun 2024 | - | $442.00K(-89.4%) | $11.72M(-43.7%) |
Mar 2024 | - | $4.17M(+18.2%) | $20.80M(-6.7%) |
Dec 2023 | $22.29M(+9.1%) | $3.53M(-1.3%) | $22.29M(+2.3%) |
Sep 2023 | - | $3.58M(-62.4%) | $21.78M(+11.2%) |
Jun 2023 | - | $9.52M(+68.1%) | $19.59M(+33.7%) |
Mar 2023 | - | $5.66M(+87.4%) | $14.65M(-28.3%) |
Dec 2022 | $20.43M(-45.6%) | $3.02M(+117.9%) | $20.43M(-18.2%) |
Sep 2022 | - | $1.39M(-69.7%) | $24.97M(-24.9%) |
Jun 2022 | - | $4.58M(-60.0%) | $33.27M(-13.2%) |
Mar 2022 | - | $11.44M(+51.2%) | $38.31M(+2.0%) |
Dec 2021 | $37.57M(-19.7%) | $7.57M(-21.9%) | $37.57M(-29.6%) |
Sep 2021 | - | $9.69M(+0.7%) | $53.34M(-13.3%) |
Jun 2021 | - | $9.62M(-10.2%) | $61.50M(+8.2%) |
Mar 2021 | - | $10.71M(-54.1%) | $56.86M(+21.5%) |
Dec 2020 | $46.79M(+576.5%) | $23.34M(+30.8%) | $46.79M(+74.1%) |
Sep 2020 | - | $17.84M(+258.7%) | $26.88M(+161.7%) |
Jun 2020 | - | $4.97M(+681.0%) | $10.27M(+52.6%) |
Mar 2020 | - | $637.00K(-81.4%) | $6.73M(-2.7%) |
Dec 2019 | $6.92M(+477.4%) | $3.43M(+177.6%) | $6.92M(+82.7%) |
Sep 2019 | - | $1.23M(-13.9%) | $3.79M(+25.6%) |
Jun 2019 | - | $1.43M(+73.9%) | $3.02M(+50.7%) |
Mar 2019 | - | $824.00K(+179.3%) | $2.00M(+66.9%) |
Dec 2018 | $1.20M(+16.5%) | $295.00K(-36.3%) | $1.20M(+24.7%) |
Sep 2018 | - | $463.00K(+10.8%) | $961.00K(+26.3%) |
Jun 2018 | - | $418.00K(+1800.0%) | $761.00K(+106.8%) |
Mar 2018 | - | $22.00K(-62.1%) | $368.00K(-67.8%) |
Dec 2017 | $1.03M(-32.4%) | $58.00K(-77.9%) | $1.14M(-37.3%) |
Sep 2017 | - | $263.00K(+952.0%) | $1.83M(-20.2%) |
Jun 2017 | - | $25.00K(-96.9%) | $2.29M(-1.3%) |
Mar 2017 | - | $798.00K(+7.8%) | $2.32M(+52.3%) |
Dec 2016 | $1.52M | $740.00K(+2.1%) | $1.52M(+63.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | $725.00K(+1242.6%) | $932.00K(+233.0%) |
Jun 2016 | - | $54.00K(+2600.0%) | $279.90K(-22.9%) |
Mar 2016 | - | $2000.00(-98.7%) | $362.90K(-68.3%) |
Dec 2015 | $1.14M(-28.2%) | $151.00K(+107.1%) | $1.14M(-52.7%) |
Sep 2015 | - | $72.90K(-46.8%) | $2.42M(-3.5%) |
Jun 2015 | - | $137.00K(-82.5%) | $2.51M(+5.7%) |
Mar 2015 | - | $782.10K(-45.2%) | $2.37M(+48.9%) |
Dec 2014 | $1.59M(>+9900.0%) | $1.43M(+789.6%) | $1.59M(+859.0%) |
Sep 2014 | - | $160.30K(+6869.6%) | $166.00K(+802.2%) |
Jun 2014 | - | $2300.00(-32.4%) | $18.40K(+14.3%) |
Mar 2014 | - | $3400.00(>+9900.0%) | $16.10K(+26.8%) |
Dec 2013 | $12.70K(>+9900.0%) | $0.00(-100.0%) | $12.70K(0.0%) |
Sep 2013 | - | $12.70K(>+9900.0%) | $12.70K(>+9900.0%) |
Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2012 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
Sep 2012 | - | $0.00(0.0%) | $10.70K(-24.6%) |
Jun 2012 | - | $0.00(0.0%) | $14.20K(-54.3%) |
Mar 2012 | - | $0.00(-100.0%) | $31.10K(0.0%) |
Dec 2011 | $31.10K(>+9900.0%) | $10.70K(+205.7%) | $31.10K(+32.9%) |
Sep 2011 | - | $3500.00(-79.3%) | $23.40K(+17.6%) |
Jun 2011 | - | $16.90K(>+9900.0%) | $19.90K(+290.2%) |
Mar 2011 | - | $0.00(-100.0%) | $5100.00(-15.0%) |
Dec 2010 | $0.00(0.0%) | $3000.00(>+9900.0%) | $6000.00(+100.0%) |
Sep 2010 | - | $0.00(-100.0%) | $3000.00(0.0%) |
Jun 2010 | - | $2100.00(+133.3%) | $3000.00(+233.3%) |
Mar 2010 | - | $900.00(>+9900.0%) | $900.00(>+9900.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2008 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2008 | - | $0.00 | $0.00 |
FAQ
- What is Iovance Biotherapeutics, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. annual CAPEX year-on-year change?
- What is Iovance Biotherapeutics, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Iovance Biotherapeutics, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. TTM CAPEX year-on-year change?
What is Iovance Biotherapeutics, Inc. annual capital expenditures?
The current annual CAPEX of IOVA is $11.07M
What is the all-time high annual CAPEX for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high annual capital expenditures is $46.79M
What is Iovance Biotherapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, IOVA annual capital expenditures has changed by -$11.22M (-50.34%)
What is Iovance Biotherapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of IOVA is $7.46M
What is the all-time high quarterly CAPEX for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high quarterly capital expenditures is $23.34M
What is Iovance Biotherapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, IOVA quarterly capital expenditures has changed by +$7.02M (+1588.01%)
What is Iovance Biotherapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of IOVA is $20.13M
What is the all-time high TTM CAPEX for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high TTM capital expenditures is $61.50M
What is Iovance Biotherapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, IOVA TTM capital expenditures has changed by +$8.41M (+71.76%)